Investors focused on AI outputs may have missed that many of the biggest tech names are quietly pivoting toward nuclear energy in a bid to find the best deals on power. Microsoft Corp. NASDAQ: MSFT is involved in the relaunch of Three Mile Island, for example, while Alphabet Inc. NASDAQ: GOOGL and Kairos Power partnered on a fleet of small modular reactors (SMRs).
In response, investors have shifted their attention to SMR developers like NuScale Power NYSE: SMR—companies with a focus on SMRs but with a limited history (if any) of generating commercial kilowatt-hours. This overlooks a crucial step in the nuclear energy supply chain: fuel. A chronically underinvested industry, Western uranium mining, conversion, and enrichment fall short of the demand for nuclear energy. The 2024 Prohibiting Russian Uranium Imports Act may force domestic companies to seek new fuel sources when its waivers expire in 2028. This means that nuclear fuel companies like Cameco Corp. NYSE: CCJ, Centrus Energy Corp. NYSE: LEU, and BWX Technologies Inc. NYSE: BWXT may suddenly become the picks and shovels of nuclear power.
CCJ: Key Positioning in the Supply Chain, But Contract and Cost Difficulties
Cameco Today
$64.93 -1.06 (-1.60%) As of 10:38 AM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $65.04
▼
$135.24 - Dividend Yield
- 0.26%
- P/E Ratio
- 98.29
- Price Target
- $148.12
Cameco stands out as the largest publicly traded uranium producer in the Western Hemisphere, with operations in Canada, Kazakhstan, and more. The company controls the conversion capacity at a key facility in Ontario, making it an essential non-Russian provider of the gas that the enrichment process requires.
The firm has also established its position in reactor services and fuel fabrication through its investment in Westinghouse, diversifying its business and giving it exposure to other key bottlenecks in the supply chain.
Still, Cameco has lagged behind the rising price of uranium, in part because of its disappointing Q3 2026 earnings, which included lower production and higher costs. The company also has long-term contracts with pricing provisions that can limit its immediate upside from higher spot prices. While Cameco has great potential to dominate as a nuclear fuel provider, investors should keep an eye on its costs, its efficiency, and how it is able to navigate new contracts going forward. If successful, it could turn around its year-to-date (YTD) decline of almost 27% and begin to generate some of the upside that analysts have predicted.
LEU: Critical Role in Producing HALEU, Though a Potential Problem in Russian Reliance
Centrus Energy Today
LEU
Centrus Energy
$94.87 -2.66 (-2.73%) As of 10:38 AM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $84.86
▼
$345.60 - P/E Ratio
- 27.78
- Price Target
- $184.89
As the only domestically licensed facility producing high-assay low-enriched uranium (HALEU), Centrus has a particularly crucial role to play in the generation of nuclear power from U.S. sources. Centrus' partnership with the Department of Energy makes it an excellent choice for a single company that is especially likely to benefit from a reactor fuel shortage.
However, investors should keep in mind that Centrus has traditionally relied on enriched uranium from Russia thanks to waivers allowing for imports. If the waivers are canceled due to tightening regulations, the company may face a situation in which it suddenly has to significantly increase domestic capacity—in the meantime, there may be a major revenue drop. If waivers continue—or if U.S.-Russia antagonism softens and restrictions are loosened—Centrus could lose some of its advantageous position.
This uncertainty may be part of the reason why LEU shares have not performed better this year. Indeed, the stock is down significantly, declining more than 59% YTD despite broad support from analysts.
BWXT: Multiple Angles Within the Nuclear Energy Space
BWX Technologies Today
BWXT
BWX Technologies
$119.62 +2.53 (+2.16%) As of 10:38 AM Eastern
This is a fair market value price provided by Massive. Learn more. - 52-Week Range
- $112.54
▼
$241.82 - Dividend Yield
- 0.90%
- P/E Ratio
- 29.31
- Price Target
- $205.00
BWX Technologies provides nuclear components, fuel, and services, with recent success in nuclear reactors and related equipment for the U.S. Navy. The lucrative partnership has boosted the firm's backlog even as its most recent earnings report was mixed: BWXT beat adjusted earnings per share (EPS) expectations by seven cents but was more than $17 million short of revenue predictions, despite a 10% year-over-year (YOY) improvement.
Not only is demand for BWX's products significant, but it has successfully improved productivity, manufacturing volumes, and free cash flow.
Investors should beware that BWX may be a less direct play on the fuel portion of the nuclear energy industry than the firms above, although its Lynchburg TRISO fuel facility could at least quadruple its output through upgrades to the existing plant.
Still, BWXT shares have also suffered this year, falling by about 32% YTD. That's little concern for Wall Street analysts, who still view the company quite favorably and assign it a Moderate Buy rating overall. The average analyst price target implies more than 75% potential upside, as earnings are projected to grow by about 10% in the coming year.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.